| Mok, Chi Chiu |
NCT04091243: Romosozumab Versus Denosumab for Osteoporosis in Long-term Glucocorticoid Users |
|
|
| Completed | 4 | 70 | RoW | Romosozumab | Tuen Mun Hospital | Glucocorticoid-induced Osteoporosis | 10/23 | 11/23 | | |
NCT06472050: Romosozumab Versus Denosumab in GIOP: a 2-year Extension Study |
|
|
| Recruiting | 4 | 63 | RoW | Romosozumab, Evenity (brand names), Denosumab, Prolia (brand name) | Tuen Mun Hospital | Osteoporosis, Glucocorticoids Toxicity | 12/25 | 03/26 | | |
NCT04748939: Shingrix in Patients With Rheumatic Diseases: a Double-blind Placebo-controlled RCT |
|
|
| Not yet recruiting | 4 | 140 | RoW | recombinant subunit herpes zoster vaccine, Shingrix | Tuen Mun Hospital | Herpes Zoster | 12/25 | 07/26 | | |
NCT05182203: Safety and Retention Rate of the JAK and TNF Inhibitors in Rheumatoid Arthritis: a Real-life Experience |
|
|
| Completed | N/A | 1732 | RoW | biologic/targeted therapy | Tuen Mun Hospital | Rheumatoid Arthritis, Drug Use | 09/22 | 10/22 | | |
NCT06335550: Surgical and Patient Reported Outcomes in Robotic Mastectomy |
|
|
| Completed | N/A | 29 | RoW | Robotic mastectomy | Changi General Hospital | Breast Cancer | 12/23 | 03/24 | | |
NCT04089930: Long-term Immunogenicity of a Live Herpes Zoster Vaccine in Systemic Lupus Erythematosus (SLE) Patients |
|
|
| Completed | N/A | 68 | RoW | Immunogenicity | Tuen Mun Hospital, The University of Hong Kong | Lupus Erythematosus | 09/23 | 10/23 | | |
| Nyaw, Shi Feng |
LUN109, NCT06055465: Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab in Resectable Non-Small Cell Lung Cancer |
|
|
| Recruiting | 2 | 37 | RoW | Sacituzumab Govitecan, Pembrolizumab | Chinese University of Hong Kong | Lung Cancer | 12/28 | 12/29 | | |
| Completed | N/A | 179 | Europe, Canada, RoW | | Takeda | Non-small Cell Lung Cancer (NSCLC) | 02/23 | 02/23 | | |
